The Future of Diffuse Large B-Cell Lymphoma (DLBCL) Treatment: Insights from Global Research November 16, 2024
BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024 November 6, 2024
Elicera Therapeutics includes the first patient in the Phase I/II clinical study CARMA targeting B-cell lymphoma November 5, 2024